Measurable Residual IDH2 before Allogeneic Transplant for Acute Myeloid Leukemia

被引：1

作者：

Gui, Gege ^{[1
,2
]}

Dillon, Laura W. ^{[1
]}

Ravindra, Niveditha ^{[1
]}

Hegde, Pranay S. ^{[1
]}

Andrew, Georgia ^{[1
]}

Mukherjee, Devdeep ^{[1
]}

Wong, Zoe ^{[1
]}

Auletta, Jeffery J. ^{[3
,4
]}

El Chaer, Firas ^{[5
]}

Chen, Evan C. ^{[6
]}

Chen, Bin ^{[7
]}

Corner, Adam ^{[8
]}

Devine, Steven M. ^{[9
]}

Iyer, Sunil G. ^{[10
]}

Jimenez, Antonio M. Jimenez ^{[11
]}

De Lima, Marcos ^{[12
]}

Litzow, Mark R. ^{[13
]}

Kebriaei, Partow ^{[14
]}

Saber, Wael ^{[4
,15
]}

Spellman, Stephen R. ^{[4
,16
]}

Zeger, Scott L. ^{[2
]}

Page, Kristin M. ^{[4
,15
]}

Hourigan, Christopher S. ^{[17
]}

机构：

[1] Natl Heart Lung & Blood Inst, Hematol Branch, Lab Myeloid Malignancies, Bethesda, MD USA

[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA

[3] Nationwide Childrens Hosp, Hematol Oncol Bone Marrow Transplant & Infect Dis, Columbus, OH USA

[4] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA

[5] Univ Virginia, Div Hematol & Oncol, Dept Med, Comprehens Canc Ctr,Med Ctr, Charlottesville, VA USA

[6] Dana Farber Canc Inst, Boston, MA USA

[7] Massachusetts Gen Hosp, Boston, MA USA

[8] Biorad Labs, Pleasanton, CA USA

[9] Natl Marrow Donor Program Be Match, CIBMTR Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA

[10] Columbia Univ, Div Hematol & Oncol, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY USA

[11] Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL USA

[12] Ohio State Univ, Div Hematol, Wexner Med Ctr, Columbus, OH USA

[13] Mayo Clin, Div Hematol, Rochester, MN USA

[14] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX USA

[15] Med Coll Wisconsin, Milwaukee, WI USA

[16] Natl Marrow Donor Program, Minneapolis, MN USA

[17] NIH, Myeloid Malignancies Program, Bethesda, MD USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-186822

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[11] Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia
Ragon, Brittany Knick
DiNardo, Courtney D.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (06) : 537 - 546
[12] Spontaneous molecular response of IDH2 acute myeloid leukemia
Khalife-Hachem, Sabine
Pegliasco, Jean
Saada, Veronique
Hernandez, Eric
Camara-Clayette, Valerie
Cotteret, Sophie
Benabdelali, Raouf
de Botton, Stephane
Marzac, Christophe
Micol, Jean-Baptiste
ANNALS OF HEMATOLOGY, 2020, 99 (02) : 353 - 354
[13] Measurable Residual Disease Detection of IDH1 or IDH2 Mutations Post but Not Prior to Allogeneic Hematopoietic Stem Cell Transplantation Show High Prognostic Relevance in Patients with Acute Myeloid Leukemia
Jendro, Jacob
Bischof, Lara
Ussmann, Jule
Thanh, Tung Pham
Backhaus, Donata
Brauer, Dominic
Vucinic, Vladan
Herling, Carmen
Herling, Marco
Franke, Georg-Nikolaus
Merz, Maximilian
Metzeler, Klaus H.
Platzbecker, Uwe
Schwind, Sebastian
Jentzsch, Madlen
BLOOD, 2024, 144 : 4334 - 4335
[14] Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia
Brittany Knick Ragon
Courtney D. DiNardo
Current Hematologic Malignancy Reports, 2017, 12 : 537 - 546
[15] Spontaneous molecular response of IDH2 acute myeloid leukemia
Sabine Khalife-Hachem
Jean Pegliasco
Véronique Saada
Eric Hernandez
Valerie Camara-Clayette
Sophie Cotteret
Raouf Benabdelali
Stephane de Botton
Christophe Marzac
Jean-Baptiste Micol
Annals of Hematology, 2020, 99 : 353 - 354
[16] Implication of IDH1 and IDH2 gene mutations in acute myeloid leukemia
Llopis, Laura
Nibourel, Olivier
Boissel, Nicolas
Huchette, Pascal
Renneville, Aline
Abdelhamid, Emma
Dombret, Herve
Preudhomme, Claude
HEMATOLOGIE, 2011, 17 (02): : 132 - 144
[17] IDH1 and IDH2 Mutations In Pediatric Acute Myeloid Leukemia.
Andersson, Anna
Miller, David
Lynch, John
Lemoff, Andrew
Cai, Zhongling
Pounds, Stanley
Radtke, Ina
Bing, Yan
John, Schuetz
Jeffrey, Rubnitz
Ribeiro, Raul
Raimondi, Susana C.
Zhang, Jinghui
Shurtleff, Sheila
Schulman, Brenda
Downing, James
BLOOD, 2010, 116 (21) : 712 - 712
[18] Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Stein, Eytan M.
DiNardo, Courtney D.
Pollyea, Daniel A.
Fathi, Amir T.
Roboz, Gail J.
Altman, Jessica K.
Stone, Richard M.
DeAngelo, Daniel J.
Levine, Ross L.
Flinn, Ian W.
Kantarjian, Hagop M.
Collins, Robert
Patel, Manish R.
Frankel, Arthur E.
Stein, Anthony
Sekeres, Mikkael A.
Swords, Ronan T.
Medeiros, Bruno C.
Willekens, Christophe
Vyas, Paresh
Tosolini, Alessandra
Xu, Qiang
Knight, Robert D.
Yen, Katharine E.
Agresta, Sam
de Botton, Stephane
Tallman, Martin S.
BLOOD, 2017, 130 (06) : 722 - 731
[19] Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia
Petiti, Jessica
Rosso, Valentina
Croce, Eleonora
Franceschi, Vanessa
Andreani, Giacomo
Dragani, Matteo
De Gobbi, Marco
Lunghi, Monia
Saglio, Giuseppe
Fava, Carmen
Lo Iacono, Marco
Cilloni, Daniela
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
[20] NPMC COOPERATES WITH MUTANT IDH2 TO INDUCE ACUTE MYELOID LEUKEMIA
Ogawara, Yoko
Katsumoto, Takuo
Aikawa, Yukiko
Kagiyama, Yuki
Kitabayashi, Issay
EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S55 - S55

← 1 2 3 4 5 →